Henrich Jill 4
4 · Atara Biotherapeutics, Inc. · Filed Mar 5, 2025
Insider Transaction Report
Form 4
Henrich Jill
EVP, Chief Regulatory Officer
Transactions
- Sale
Common Stock
2025-03-03$7.00/sh−1,059$7,410→ 18,679 total
Footnotes (3)
- [F1]Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement.
- [F2]The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on March 3, 2025 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.
- [F3]This amount includes 360 shares purchased under the Issuer's Employee Stock Purchase Plan on November 29, 2024.